WO2008056221A3 - Crystalline sulfate salt of cephalosporin antibiotic - Google Patents

Crystalline sulfate salt of cephalosporin antibiotic Download PDF

Info

Publication number
WO2008056221A3
WO2008056221A3 PCT/IB2007/003341 IB2007003341W WO2008056221A3 WO 2008056221 A3 WO2008056221 A3 WO 2008056221A3 IB 2007003341 W IB2007003341 W IB 2007003341W WO 2008056221 A3 WO2008056221 A3 WO 2008056221A3
Authority
WO
WIPO (PCT)
Prior art keywords
sulfate salt
cephalosporin antibiotic
crystalline sulfate
cephalosporin
crystalline
Prior art date
Application number
PCT/IB2007/003341
Other languages
French (fr)
Other versions
WO2008056221A2 (en
Inventor
Rajendra Janardan Sarangdhar
Balasubramanian Jothimani
Abdul Mohammed Jaffar
Sekar Selvakumar
Pramod Narayan Deshpande
Original Assignee
Orchid Chemicals & Pharm Ltd
Rajendra Janardan Sarangdhar
Balasubramanian Jothimani
Abdul Mohammed Jaffar
Sekar Selvakumar
Pramod Narayan Deshpande
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orchid Chemicals & Pharm Ltd, Rajendra Janardan Sarangdhar, Balasubramanian Jothimani, Abdul Mohammed Jaffar, Sekar Selvakumar, Pramod Narayan Deshpande filed Critical Orchid Chemicals & Pharm Ltd
Publication of WO2008056221A2 publication Critical patent/WO2008056221A2/en
Publication of WO2008056221A3 publication Critical patent/WO2008056221A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

The present invention relates to novel crystalline form of cephalosporin sulfate of the following formula and provides a process for preparing the same.
PCT/IB2007/003341 2006-11-06 2007-11-05 Crystalline sulfate salt of cephalosporin antibiotic WO2008056221A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2043CH2006 2006-11-06
IN2043/CHE/2006 2006-11-06

Publications (2)

Publication Number Publication Date
WO2008056221A2 WO2008056221A2 (en) 2008-05-15
WO2008056221A3 true WO2008056221A3 (en) 2008-07-17

Family

ID=39364883

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/003341 WO2008056221A2 (en) 2006-11-06 2007-11-05 Crystalline sulfate salt of cephalosporin antibiotic

Country Status (1)

Country Link
WO (1) WO2008056221A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101880291B (en) * 2010-07-07 2012-05-30 福建省福抗药业股份有限公司 Preparation method of cefpirome sulfate sterile powder

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0112550A2 (en) * 1982-12-28 1984-07-04 Hoechst Aktiengesellschaft Crystalline acid addition salts of cephalosporins and process for their preparation
DE3626375A1 (en) * 1985-08-05 1987-02-12 Bristol Myers Co CEPHALOSPORINE SALTS AND INJECTABLE AGENTS CONTAINING THEM
KR100293728B1 (en) * 1998-05-22 2001-09-17 손 경 식 Process for producing crystalline cefpirom sulfate

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0112550A2 (en) * 1982-12-28 1984-07-04 Hoechst Aktiengesellschaft Crystalline acid addition salts of cephalosporins and process for their preparation
DE3626375A1 (en) * 1985-08-05 1987-02-12 Bristol Myers Co CEPHALOSPORINE SALTS AND INJECTABLE AGENTS CONTAINING THEM
KR100293728B1 (en) * 1998-05-22 2001-09-17 손 경 식 Process for producing crystalline cefpirom sulfate

Also Published As

Publication number Publication date
WO2008056221A2 (en) 2008-05-15

Similar Documents

Publication Publication Date Title
WO2008155615A3 (en) An improved process for the preparation of cephalosporin antibiotic
WO2008062279A3 (en) An improved process for the preparation of carbapenem antibiotic
EP1934221A4 (en) An improved process for the preparation of beta-lactam antibiotic
ZA200708071B (en) Crystalline form of a quinolinone-carboxamide compound
WO2010097229A3 (en) Amorphous salt of a macrocyclic inhibitor of hcv
WO2010001257A3 (en) Novel solid state forms of laquinimod and its sodium salt
WO2008053334A3 (en) An improved process for preparing rosuvastatin calcium
ZA200905832B (en) Crystalline forms of an 8-azabicyclo [3.2.1] octane compound
WO2012038979A3 (en) A process for preparation of ertapenem
WO2007099552A3 (en) Novel crystalline form of atovastatin hemi-magnesium
GB2456096B (en) Crystalline form of benzothiophene compound and process for preparation thereof
WO2008015703A3 (en) Process for the preparation of montelukast and its salts thereof
WO2007013043A3 (en) Processes for the preparation of 7-amino-3-vinyl cephalosporanic acid
EP2209787A4 (en) Process for the preparation of carbapenem antibiotic
IL186670A0 (en) Method for producing strains of overproductive staphylococcus aureus
EP1990336A4 (en) Process for production of 5-alkoxy-4-hydroxymethylpyrazole compound
WO2006053625A8 (en) Crystalline form of cefdinir ammonium salt as an intermediate for the preparation of pure cefdinir
WO2010146348A3 (en) Crystalline form of pemirolast
WO2008082562A3 (en) Aminothiazole macrocycles, their use as antibacterial compounds and processes for their production
WO2008056221A3 (en) Crystalline sulfate salt of cephalosporin antibiotic
EP2188287A4 (en) Acid addition salts of synthetic intermediates for carbapenem antibiotics and processes for preparing the same
EP1852436A4 (en) Process for production of carbapenem derivative and crystalline intermediate therefor
HK1144192A1 (en) Stable crystalline salt of (r)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabiciyclo [2.2.2]oct-3-yl ester (r)-3--345- 1-[222]
WO2007044490A3 (en) Process for making heteroaryl amine intermediate compounds
WO2010020871A8 (en) Crystalline sodium salt of cephalosporin antibiotic

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07825586

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07825586

Country of ref document: EP

Kind code of ref document: A2